Provided by Tiger Trade Technology Pte. Ltd.

INNOCARE

14.790
+0.3202.21%
Volume:14.26M
Turnover:210.01M
Market Cap:26.13B
PE:33.32
High:14.950
Open:14.430
Low:14.190
Close:14.470
52wk High:20.180
52wk Low:9.650
Shares:1.77B
HK Float Shares:1.49B
Volume Ratio:1.29
T/O Rate:0.95%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.444
ROE:12.77%
ROA:4.28%
PB:2.92
PE(LYR):33.32
PS:8.05

Loading ...

Innovative Drug Sector Maintains Upward Momentum on Favorable Regulatory Developments and Accelerating Internationalization

Stock News
·
Jul 06

Innocare's Stock Surges Over 9% as First Patient Dosed with Novel In-house Developed CDH17-Targeting ADC Drug

Deep News
·
Jul 06

Movement Alert|InnoCare Pharma Rises 6.65% in Regular Trading, Self-Developed ADC Drug ICP-B208 Completes First Patient Dosing

Market Focus
·
Jul 06

Hong Kong Innovative Drug Stocks Jump With HAIXI PHARMA and INNOCARE up 7%; KEYMED up 5%, REMEGEN up 4%

Tiger Newspress
·
Jul 06

Innocare Shares Surge Over 8% Following First Patient Dosing of Novel In-House ADC Drug

Stock News
·
Jul 06

InnoCare issues 1.91 million RSUs under 2023 Share Award Scheme, equal to 0.11% of share capital

Bulletin Express
·
Jun 30

Innocare Pharma Issues 2.42 Million New Shares Under 2024 Equity Incentive Plan

Stock News
·
Jun 26

Extensive Orelabrutinib Data Across Regions Might Change The Case For Investing In InnoCare Pharma (SEHK:9969)

Simply Wall St.
·
Jun 22

InnoCare Pharma (SEHK:9969) Stock Could Be 45% Undervalued After EHA 2026 Data

Simply Wall St.
·
Jun 21

Innocare Pharma Shares Surge Over 5% on Positive Phase III Data for Tafasitamab Combo in Frontline DLBCL

Stock News
·
Jun 18

INNOCARE Issues 8 Million Restricted Shares Under Incentive Plan

Stock News
·
Jun 16

InnoCare issues 8.00 million restricted shares (0.45% stake) in first tranche of 2026 RMB Share Incentive Scheme

Bulletin Express
·
Jun 16

InnoCare Pharma: Shareholders Overwhelmingly Approve All 24 Resolutions at 2026 AGM

Bulletin Express
·
Jun 16

Innovative Drug Stocks See Broad Gains as Sector's Outbound Licensing Activity Remains Robust, Supported by Policy Tailwinds and Commercialization Progress

Stock News
·
Jun 12

Innocare Appoints Yuan Bei as Joint Company Secretary

Stock News
·
Jun 05

A Look At InnoCare Pharma (SEHK:9969) Valuation After Recent Share Price Weakness

Simply Wall St.
·
Jun 03

InnoCare Pharma Gets Acceptance for ITP New Drug Application; Shares Up 3%

MT Newswires Live
·
May 29

Innocare's New Drug Application for Orelabrutinib in ITP Accepted for Review by NMPA

Stock News
·
May 28

InnoCare Pharma Wins Australia Approval for Lymphoma Drug

MT Newswires Live
·
May 28

Innocare Pharma's Orelabrutinib Receives Marketing Authorization from Australian TGA

Stock News
·
May 27